Archive

Soda ingredient poses cancer risk

Public health researchers have analyzed soda consumption data in order to characterize people’s exposure to a potentially carcinogenic byproduct of some types of caramel color.

Risk of anastomotic failure after non-elective surgery rises with NSAID use

by Bruce Sylvester: Post-surgical nonsteroidal anti-inflammatory drug (NSAID) therapy appears to entail an increased risk of anastomotic leak at the surgical junction among patients who have undergone non-elective… read more.

World population gains more than 6 years of life

Despite global improvements in life expectancy, death rates for some causes — including drug use and liver cancer — continue to rise.  Global life expectancy increased by 5.8… read more.

ASH 2015: How do you see the newer agents being used in the up-front setting in HL? An interview with Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA. Click on the video image to view.

ASH 2014 Video Interview by Esther Drain: Highlights from the 2014 ASH Annual Meeting with Stephen Ansell, Robert Chen & Ajay Gopal

Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA.  Dr Robert Chen, City of Hope, Duarte, CA, USA.  Professor Ajay Gopal, University of Washington, WA, USA.

Australian study casts doubt on sepsis guidelines

World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.

ASH 2014: T-cell lymphomas: a challenge for clinicians

by Thomas R. Collins: Treating patients with T-cell lymphomas is fraught with challenges, requiring new approaches and sharper diagnosis, said Timothy Illidge, MD, PhD, Professor of Targeted Therapy… read more.

ASH 2014: Chimeric antigen receptor T cells shows promise in lymphoma

by Thomas R. Collins: The use of chimeric antigen receptor T-cells — in which a patient’s own T cells are modified to fight cancer cells — is showing good results… read more.

ASH 2014 Video Interview by Esther Drain: Hodgkin Lymphoma: Prognosis and Therapy. Professor Ajay Gopal (University of Washington) discusses where we are with prognostic biomarkers and interim PET scans to direct therapy in HL

by Thomas R. Collins: Pursuit of useful risk biomarkers in HL still a work-in-progress. The quest for biomarkers in classic Hodgkin lymphoma, to determine which patients are at a… read more.

ASH 2014 Video Interview by Esther Drain: Practice Changing News from ASH with Stephen Ansel, John Sweetenham & Ajay Gopal

Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA.  Professor John Sweetenham, Hunstman Cancer Institute, Saltlake City, USA.  Professor Ajay Gopal, University of Washington, WA, USA.

All in the words!

Ache, agony, distress and pain draw more attention than non-pain related words when it comes to people who suffer from chronic pain.

WTC Report 2014: Update on worldwide causes of morbidity and mortality in living donor liver transplantation

By Allan M Concejero et al, Kaohsiung Chang Gung Memorial Hospital, Taiwan.  Increased use of living donors for liver transplantations has meant an increase in donor complications and… read more.